Acumen Pharmaceuticals Balance Sheet (2020-2026) | ABOS

Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
68.81M135.80M122.16M108.76M111.07M157.54M129.10M78.00M77.25M94.92M66.20M46.93M67.60M33.18M35.30M30.16M36.81M46.83M53.99M51.80M
Short-term Investments (Quarter)
64.16M72.08M80.33M78.84M42.65M47.50M62.41M67.63M120.52M176.64M205.58M192.52M167.16M135.93M118.99M106.56M79.78M62.88M76.60M
Cash & Current Investments (Quarter)
68.81M199.96M194.24M189.09M189.91M200.19M176.60M140.41M144.88M215.43M242.84M252.51M260.12M200.34M171.23M149.15M143.37M126.61M116.86M128.40M
Receivables - Other (Quarter)
0.11M0.11M0.23M0.19M0.11M0.27M0.34M0.38M0.32M0.38M0.62M0.77M
Prepaid Assets (Quarter)
1.65M4.84M4.42M3.01M1.14M2.37M0.24M3.62M0.21M0.18M3.82M3.32M0.41M0.46M6.75M5.80M5.50M5.94M5.39M5.00M
Current Assets (Quarter)
70.57M204.91M198.66M192.10M191.05M202.56M180.33M144.03M149.54M218.60M246.62M255.83M266.92M207.63M178.31M154.95M148.40M132.15M122.25M133.09M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.01M0.01M0.04M0.05M0.11M0.14M0.17M0.15M0.14M0.12M0.12M0.12M0.10M0.09M
Long-Term Investments (Quarter)
29.91M31.62M27.66M20.00M15.84M43.42M27.31M67.27M62.55M44.11M20.91M58.55M59.97M48.80M22.80M9.44M
Other Non-Current Assets (Quarter)
0.01M0.01M0.01M0.08M0.11M0.20M0.21M0.19M0.23M0.23M0.23M0.24M0.49M0.23M0.23M0.23M0.23M0.23M
Non-Current Assets (Quarter)
2.37M29.94M31.67M27.99M20.62M0.70M16.26M43.83M27.87M67.77M63.51M45.14M22.00M59.34M60.69M49.53M23.49M10.07M0.58M0.54M
Assets (Quarter)
72.94M234.85M230.33M220.09M211.68M203.26M196.59M187.86M177.41M286.37M310.12M300.97M288.91M266.98M238.99M204.48M171.90M142.22M122.83M133.63M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.91M0.38M3.91M1.22M3.28M4.40M1.64M2.75M2.03M1.36M1.38M3.08M4.21M2.34M5.65M1.06M2.10M0.68M0.55M1.66M
Notes Payables (Quarter)
3.60M8.77M14.12M
Payables (Quarter)
2.91M0.38M3.91M1.22M3.28M4.40M1.64M2.75M2.03M1.36M1.38M3.08M4.21M2.34M5.65M1.06M2.10M4.28M9.32M15.78M
Accumulated Expenses (Quarter)
3.35M2.37M3.17M6.45M2.90M4.00M4.93M6.62M6.71M11.65M7.79M10.07M5.27M
Other Accumulated Expenses (Quarter)
0.05M0.12M0.20M0.10M0.10M0.04M
Short term Debt (Quarter)
3.60M8.77M14.12M
Current Leases (Quarter)
0.14M0.14M0.13M0.10M0.07M0.03M0.00M0.76M0.12M
Total Current Liabilities (Quarter)
5.15M3.94M5.13M6.61M7.81M8.78M8.53M6.10M12.97M8.47M15.37M19.91M27.61M19.32M24.86M21.96M30.01M29.23M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
0.24M0.34M0.18M
Preferred Stock Liabilities (Quarter)
174.50M
Operating Leases (Quarter)
0.06M0.17M0.13M0.28M0.25M0.22M0.18M
Other Non-Current Liabilities (Quarter)
0.28M0.15M0.11M0.08M0.04M
Total Non-Current Liabilities (Quarter)
42.87M57.03M48.84M54.74M49.01M52.40M
Total Liabilities (Quarter)
4.52M1.49M5.15M4.00M5.16M6.61M7.81M8.78M8.53M6.10M43.15M38.93M44.97M49.77M57.18M48.96M54.82M49.05M52.40M46.15M
Shareholder's Equity
Total Debt (Quarter)
3.60M8.77M14.12M
Common Equity (Quarter)
-106.08M233.36M225.18M216.09M206.52M196.65M188.78M179.09M168.87M280.27M266.97M262.03M243.95M217.20M181.82M155.52M117.08M93.17M70.43M87.48M
Shareholder's Equity (Quarter)
-106.08M233.36M225.18M216.09M206.52M196.65M188.78M179.09M168.87M280.27M266.97M262.03M243.95M217.20M181.82M155.52M117.08M93.17M70.43M87.48M
Liabilities and Shareholders Equity (Quarter)
72.94M234.85M230.33M220.09M211.68M203.26M196.59M187.86M177.41M286.37M310.12M300.97M288.91M266.98M238.99M204.48M171.90M142.22M122.83M133.63M
Retained Earnings (Quarter)
-115.32M-119.20M-127.57M-136.70M-146.85M-157.56M-0.75M-181.70M-193.30M-206.30M0.31M-237.67M-258.20M0.52M-0.05M-353.90M-394.87M-421.32M-446.46M0.02M
Treasury Shares (Quarter)
0.33M0.33M0.33M0.33M1.42M1.41M1.41M1.35M1.85M1.92M1.91M1.91M2.76M